Lv1
38 积分 2023-09-22 加入
A coiled-coil masking domain for selective activation of therapeutic antibodies
5天前
已完结
A novel anti-HER2/EGFR bispecific antibody–drug conjugate demonstrates promising antitumor efficacy and overcomes resistance to HER2- or EGFR-targeted ADCs
19天前
已完结
Trastuzumab Deruxtecan (T-DXd) Resistance via Loss of HER2 Expression and Binding
1个月前
已完结
Tumor Microenvironment-Responsive Antibody Fragment-Cleavable PEGylated Drug Conjugates (AFCDC) for Improved Tumor Penetration and Antitumor Efficacy
1个月前
已完结
Dual-Targeting Multivalent Aptamer-Drug Hybrids for Synergistic Cancer Immunotherapy
2个月前
已完结
Abstract 1523: Subcutaneous dosing of amatoxin-based ADCs increases the therapeutic index
3个月前
已完结
Precision Cuproptosis Activation via HER2‐Targeted Bimetallic MOF Nanoreactors Breaks Metabolic Adaptation in Aggressive Breast Cancers
3个月前
已完结
Synergistic SuFEx‐Driven Covalent Cancer Therapy Using a HER2/EGFR Bivalent Affinity Protein Drug
4个月前
已完结
Chemical Evolution of Double Covalent Aptamers for Sustained Protein Degradation and Improved Cytotoxicity in NK-Cell-Mediated Tumor Therapy
4个月前
已完结
Dimethyl itaconate attenuates IL-1-induced IVIG-resistant inflammation in a coronary artery cell model of Kawasaki disease
4个月前
已完结
皖公网安备34019202002308
